Who owns Galliprant?
Galliprant is owned by Elanco (the United States, NYSE: ELAN), which has owned the brand since 18 July 2019.[1][2]
Evidence: Elanco Animal Health Incorporated Annual Report on Form 10-K filed 2026-02-24, SEC EDGAR, 24 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Elanco Animal Health Incorporated verified
- Owned since
- Owner HQ
- 🇺🇸 United States, Indianapolis
- Origin
- 🇺🇸 United States
- Category
- Pet & animal care › Pet supplies & services › Veterinary services
- Parent ticker
- NYSE: ELAN
- Trademark registrant
- ELANCO US INC. (USPTO)
- Last verified
- · 3 sources
About Galliprant
Galliprant is a dog medicine that Elanco says controls pain and inflammation associated with osteoarthritis. According to the 10-K, patents covering its active ingredient, grapiprant, have expired in most markets, while patents covering methods of use and formulation expire in 2035. Elanco lists it in the animal-health portfolio described in its annual report on Form 10-K for the year ended 31 December 2025.
What Elanco's annual report says about Galliprant
Sentences about Galliprant from Elanco's latest annual filing[1], copied word for word.
In pain/other therapeutics, we have a broad pain portfolio for dogs and cats across modes of action, indications and disease stages, including Galliprant , which offers a convenient at home solution for osteoarthritis.
Below is a summary of our recent and upcoming key patent expirations: 11 Table of Contents Galliprant is protected by patents in the U.S., Europe, Canada, Japan and other key markets.
How often Elanco names Galliprant in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.
Trademark record for Galliprant
The USPTO record for the Galliprant mark lists ELANCO US INC. as the owner of record (serial number 86977763). That name matches the owner named above.[3]
Ownership timeline of Galliprant
Where Galliprant sits in Elanco
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Elanco ownership tree →
See the full Elanco brand portfolio (15) →
Other brands owned by Elanco
Elanco controls 15 brands on Brandtree, 15 of them in pet & animal care.
Also in pet & animal care
Other brands in veterinary services, and who owns them
The 45 brands in veterinary services on Brandtree belong to 7 owners. The largest is Zoetis, with 17; Elanco has 10.
About the owner: Elanco
Elanco is a publicly listed company headquartered in Indianapolis, United States, founded in 1954. Brandtree records 15 brands under its control, and it is listed as NYSE: ELAN.
Elanco Animal Health is an Indianapolis animal health company with pet health and farm animal businesses. Its 10-K says it has a heritage dating to 1954 as a business unit of Eli Lilly and Company, was incorporated independently in September 2018 and separated in March 2019, and in August 2020 acquired Bayer Animal Health, which it calls the largest acquisition in industry history. It sells flea and tick, dermatology and pain products for pets and feed additives, vaccines and antibiotics for livestock.
🇺🇸 Galliprant and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Galliprant is not one of them.
- 4health — Tractor Supply 🇺🇸
- American Journey — Chewy 🇺🇸
- Apoquel — Zoetis 🇺🇸
- Aqueon — Central Garden & Pet 🇺🇸
- Aureomycin — Phibro 🇺🇸
- BARK — BARK 🇺🇸
Frequently asked questions
Who is the parent company of Galliprant?
The parent company of Galliprant is Elanco, a publicly listed company headquartered in the United States.
Is Galliprant American?
Yes. Galliprant originated in the United States and its owner, Elanco, is also headquartered in the United States.
Since when has Elanco owned Galliprant?
Elanco has owned Galliprant since 18 July 2019.
Is Galliprant still owned by Elanco?
Yes. As of 9 October 2026, Galliprant is still owned by Elanco. The ownership record was last checked against primary sources on that date.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Elanco Animal Health Incorporated Annual Report on Form 10-K filed 2026-02-24 — SEC EDGAR, SEC Form 10-K, published 24 February 2026; retrieved 2 October 2026.
- [2] Elanco Finalizes Acquisition of Aratana Therapeutics — Elanco Animal Health Incorporated, Official press release, published 18 July 2019; retrieved 2 October 2026.
- [3] USPTO: GALLIPRANT, serial 86977763 — United States Patent and Trademark Office, Trademark registry; retrieved 2 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.